(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Structure
CAS No.
1640971-60-3
Chemical Name:
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
Synonyms
tofacitinib iMpurity;Tofacitinib Impurity 21;PF-05579970;Tofatib reference;ofacitinib iMpurity;Tofaimpurity iMpurity;Tofatinib Impurity 21;Tofacitinib Impurity 9;Tofacitinib Impurity 18;Tofacitinib Impurity 15
CBNumber:
CB72663305
Molecular Formula:
C14H20N6O
Molecular Weight:
288.35
MOL File:
1640971-60-3.mol
Modify Date:
2024/4/25 13:42:50

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Properties

Melting point 238 - 240°C
Boiling point 551.0±50.0 °C(Predicted)
Density 1.249±0.06 g/cm3(Predicted)
storage temp. Refrigerator
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka 6.06±0.60(Predicted)
form Solid
color White to Off-White

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Chemical Properties,Uses,Production

Uses

Tofacitinib Citrate Impurity is derived from (3R,?4R)?-N,?4-?Dimethyl-?1-?benzyl?-3-?piperidinamine (D464895), which is a reagent used in the preparation of Janus tyrosine kinase inhibitors for the treatment of autoimmune diseases.

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 88)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29820 58 Inquiry
ANHUI WITOP BIOTECH CO., LTD +8615255079626 China 23555 58 Inquiry
AFINE CHEMICALS LIMITED +86-0571-85134551 China 15372 58 Inquiry
CR Corporation Limited +8613062833949 China 8647 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
LEAPCHEM CO., LTD. +86-852-30606658 China 43348 58 Inquiry
ShenZhen H&D Pharmaceutical Technology Co., LTD +8618627948422 China 3389 58 Inquiry
ofacitinib iMpurity Tofacitinib Citrate Impurity Tofacitinib Impurity 11 Tofacitinib Impurity 14 Tofacitinib Impurity 15 Tofacitinib Impurity 18 Tofacitinib Impurity 9 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl) (methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate-one Tofacitinib Impurity TBA Tofacitinib Impurity 5 DiHCl N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine PF-05579970 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Tofaimpurity iMpurity Tofacitinib Related Compound 11 butyl (E)-3-amino-2-cyano-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopent-2-enoate Tofacitinib Impurity TAB 1-Piperidinepropanenitrile, 3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-, (3R,4R)- Tofatib reference Tofacitinib Impurities1006 Tofacitinib Impurities1007 Tofacitinib Impurities1008 Tofacitinib Impurities1009 3-[3-((6-Amino-pyrimidin-4-yl)-methyl-amino)-4-methyl-piperidin-1-yl]-3-oxo-propionitrile tofacitinib iMpurity Tofacitinib Impurity 21 3-((3R,4R)-3-((6-Aminopyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile (Tofacitinib Impurity) 1-Piperidinepropanenitrile, 3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-, (3R,4R)- Tofatinib Impurity 21 (3R,4R)-3-[(6-Amino-4-pyrimidinyl)methylamino]-4-methyl-Beta-oxo-1-piperidinepropanenitrile 1640971-60-3 ZJ ZY